Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/04/2007CA2679608A1 Methods and compositions for treating hypercholesterolemia and atherosclerosis
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/04/2007CA2647579A1 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment
10/04/2007CA2647533A1 Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
10/04/2007CA2647512A1 Substance exhibiting neuromodulator activity
10/04/2007CA2647425A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647423A1 Triazolone derivative
10/04/2007CA2647422A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647417A1 Buprenorphine derivatives and uses thereof
10/04/2007CA2647378A1 Dental appliance cleanser
10/04/2007CA2647348A1 Formulations of low dose diclofenac and beta-cyclodextrin
10/04/2007CA2647290A1 Piperidines and related compounds for the treatment of dementia
10/04/2007CA2647235A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
10/04/2007CA2647163A1 Modified macrophage migration inhibitory factor inhibitors
10/04/2007CA2647123A1 Mucosal bioadhesive slow release carrier for delivering active principles
10/04/2007CA2647116A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007CA2647048A1 Methods for treating cognitive and other disorders
10/04/2007CA2647038A1 Inhibitors of protein prenyltransferases
10/04/2007CA2646952A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007CA2646712A1 Novel method
10/04/2007CA2646701A1 C-met protein kinase inhibitors for the treatment of proliferative disorders
10/04/2007CA2646700A1 Terguride/proterguride for the treatment of chronic pain
10/04/2007CA2646280A1 Stable aqueous suspension concentrate for delivery of uv-labile water-insoluble biocides
10/04/2007CA2646244A1 Tetracycline compounds and methods of treatment
10/04/2007CA2645946A1 Inhibitors of protein aggregation
10/04/2007CA2645919A1 Thioninium compounds and their use
10/04/2007CA2645859A1 2'-fluoronucleoside phosphonates as antiviral agents
10/04/2007CA2645791A1 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/04/2007CA2645779A1 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007CA2645756A1 Malonamide derivatives as gamma secretase inhibitors
10/04/2007CA2645639A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/04/2007CA2645581A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007CA2645494A1 Methods and compositions for making and using polymorphs of cinacalcet
10/04/2007CA2645488A1 Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
10/04/2007CA2645487A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007CA2645281A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007CA2645099A1 Methods for modulating bladder function
10/04/2007CA2644911A1 Antibiotic compositions of modified release and process of production thereof
10/04/2007CA2644662A1 New therapeutic combinations for the treatment of depression
10/04/2007CA2644656A1 Treatment of pain
10/04/2007CA2644639A1 New therapeutic combinations for the treatment or prevention of psychotic disorders
10/04/2007CA2644621A1 Dsrna compositions and methods for treating hpv infection
10/04/2007CA2644618A1 Methods for treating cognitive and other disorders
10/04/2007CA2644585A1 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
10/04/2007CA2644488A1 Anti-diabetic cataract compounds and their uses
10/04/2007CA2644448A1 Varenicline standards and impurity controls
10/04/2007CA2644411A1 Polylactide nanoparticles
10/04/2007CA2644369A1 Amide derivatives and their application for the treatment of g protein related diseases
10/04/2007CA2643503A1 Purine compounds and methods of use thereof
10/04/2007CA2642880A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007CA2642872A1 Improved crystalline material
10/04/2007CA2631875A1 Formulation of insoluble small molecule therapeutics in lipid-based carriers
10/03/2007EP1840224A1 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment
10/03/2007EP1840132A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
10/03/2007EP1840129A1 Imidazothiazole derivative and method for producing same
10/03/2007EP1840128A1 Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and process for producing the same
10/03/2007EP1840126A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1840123A1 Isoxazolines and their use as inhibitors of phosphodiesterase type-IV
10/03/2007EP1840122A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
10/03/2007EP1840117A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
10/03/2007EP1839677A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof
10/03/2007EP1839675A1 Novel method of protecting ischemic cardiopathy
10/03/2007EP1839665A1 Intraoral disintegration type solid preparation containing povidone iodine
10/03/2007EP1839664A1 Agent for regulating bone formation
10/03/2007EP1839663A1 Blood cholesterol reducing oral composition
10/03/2007EP1839662A1 Antitumor agent
10/03/2007EP1839661A2 Pipecolic acid-containing antidiabetic compositions
10/03/2007EP1839660A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1839658A1 Pharmaceutical composition comprising micronized nebivolol
10/03/2007EP1839657A2 A method for treating vascular headaches
10/03/2007EP1839656A1 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
10/03/2007EP1839655A1 Ctgf expression inhibitor
10/03/2007EP1839654A2 Use of (1R, 2R)-3-(3-dimenthyl amino-1-ethyl-2-methyl-propyl) phenol for treating painful inflammations
10/03/2007EP1839653A1 Therapeutic agent for sensory abnormality
10/03/2007EP1839652A1 Agents to positively influence Alzheimer's disease and/or as an Alzheimer's prophylaxis
10/03/2007EP1839651A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1839643A1 Cosmetic and pharmaceutical foam carrier
10/03/2007EP1839502A1 Fine powder of amino acid and suspension thereof
10/03/2007EP1838864A2 Antifungal properties of various forms of sophorolipids
10/03/2007EP1838853A2 Rnai agents for maintenance of stem cells
10/03/2007EP1838736A2 Cripto binding molecules
10/03/2007EP1838718A1 Pyrrolopyrazoles, potent kinase inhibitors
10/03/2007EP1838717A2 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same
10/03/2007EP1838716A1 Olanzapine pamoate dihydrate
10/03/2007EP1838714A1 Methods of treating pain
10/03/2007EP1838712A1 Pyrazolopyrimidine compounds as antitumor agents
10/03/2007EP1838710A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/03/2007EP1838709A2 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
10/03/2007EP1838708A2 Pyrrolodihydroisoquinolines as antiproliferative agents
10/03/2007EP1838707A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors
10/03/2007EP1838706A1 G-protein coupled receptor agonists
10/03/2007EP1838705A2 3,8-substituted 8-aza-bicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/03/2007EP1838704A1 Selected benzofuran derivatives
10/03/2007EP1838702A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
10/03/2007EP1838701A1 N-substituted heterocyclic sulfonamides
10/03/2007EP1838700A2 Disubstituted ureas as kinase inhibitors
1 ... 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 3577 3578 3579 ... 7860